- Home
- APGE vs TGI Comparison
APGE vs TGI Comparison
Compare APGE & TGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- TGI
- Stock Information
- Founded
- APGE 2022
- TGI 1993
- Country
- APGE United States
- TGI United States
- Employees
- APGE N/A
- TGI N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- TGI Aerospace
- Sector
- APGE Health Care
- TGI Industrials
- Exchange
- APGE Nasdaq
- TGI Nasdaq
- Market Cap
- APGE 1.8B
- TGI 2.0B
- IPO Year
- APGE 2023
- TGI 1996
- Fundamental
- Price
- APGE $39.72
- TGI $25.44
- Analyst Decision
- APGE Strong Buy
- TGI Hold
- Analyst Count
- APGE 4
- TGI 9
- Target Price
- APGE $91.33
- TGI $18.78
- AVG Volume (30 Days)
- APGE 789.9K
- TGI 1.4M
- Earning Date
- APGE 03-03-2025
- TGI 05-22-2025
- Dividend Yield
- APGE N/A
- TGI N/A
- EPS Growth
- APGE N/A
- TGI N/A
- EPS
- APGE N/A
- TGI 7.25
- Revenue
- APGE N/A
- TGI $1,242,654,000.00
- Revenue This Year
- APGE N/A
- TGI $3.52
- Revenue Next Year
- APGE $795.25
- TGI $10.94
- P/E Ratio
- APGE N/A
- TGI $149.17
- Revenue Growth
- APGE N/A
- TGI 7.23
- 52 Week Low
- APGE $29.10
- TGI $11.01
- 52 Week High
- APGE $68.21
- TGI $25.52
- Technical
- Relative Strength Index (RSI)
- APGE 55.27
- TGI 72.95
- Support Level
- APGE $38.18
- TGI $25.40
- Resistance Level
- APGE $41.07
- TGI $25.48
- Average True Range (ATR)
- APGE 2.31
- TGI 0.06
- MACD
- APGE 0.22
- TGI -0.12
- Stochastic Oscillator
- APGE 63.77
- TGI 68.52
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About TGI Triumph Group Inc.
Triumph Group Inc designs and manufactures a broad portfolio of aerostructures, aircraft components, and systems for the aviation industry. It serves a customer base of players in the commercial, business, and military markets. The company operates under two operating segments: Systems and Support, which derives key revenue and designs, develops, and supports proprietary components; and Interiors, which supplies commercial and regional manufacturers with aircraft interior systems.